Skip to main content

Find Clinical Trials

Home
Conditions
HER2-low-expressing Breast Cancer

Clinical trial condition

HER2-low-expressing Breast Cancer

Explore clinical trials studying HER2-low-expressing Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

HER2-low-expressing Breast Cancer trial results

Active, Not Recruiting

Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial

NCT05165225

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China

View Trial Details